Psilocybin modulates nucleus accumbens activity via astrocytic transcriptional regulation

Su Min Kang, Dae-Si Kang, Tae-Yong Choi, Sejin Jeong, A-Hyeon Lee, Yujeong Jeong, Minjin Oh, Eum Ji Kim, Jieun Lee, Ki Jung Kim, C. Justin Lee, Na Young Lim, Tae Woong Na, Bong Hyo Lee, Jae-sung Bae, Su-Jeong Park, Suchan Chang, Ja Wook Koo
Experimental & Molecular Medicine · Springer Nature · 2026-11-05 · DOI: 10.1038/s12276-026-01872-3

Аннотация

Experimental & Molecular Medicine, Published online: 05 November 2026; doi:10.1038/s12276-026-01872-3 Substance use disorder poses a global health challenge, with novel psychoactive substances such as synthetic tryptamines complicating the landscape. This study explores how psilocybin, a classical psychedelic tryptamine, modulates mesolimbic inhibitory signaling in the nucleus accumbens (NAc), focusing on astrocyte-specific mechanisms. Using behavioral, electrophysiological, pharmacological and molecular techniques, researchers found that psilocybin reduces extracellular GABA levels and increases neuronal activity in the NAc. Notably, psilocybin decreased tonic GABAergic inhibition without a

Читать у издателя →

Похожие статьи